Unknown

Dataset Information

0

Congestive heart failure adherence redesign trial: a pilot study.


ABSTRACT: Heart failure (HF) continues to be a leading cause of hospital admissions, particularly in underserved patients. We hypothesised that providing individualised self-management support to patients and feedback on use of evidence-based HF therapies (EBT) to physicians could lead to improvements in care and decrease hospitalisations. To assess the feasibility of conducting a larger trial testing the efficacy of this dual-level intervention, we conducted the Congestive Heart failure Adherence Redesign Trial Pilot (CHART-P), a proof-of-concept, quasi-experimental, feasibility pilot study.A large tertiary care medical centre in Chicago.Low-income patients (80% of interventions at 1 month and by study completion, respectively. Median sodium intake declined (3.5 vs 2.0 g; p<0.01). There was no statistically significant change in medication adherence based on electronic pill cap monitoring or the Morisky Medication Adherence Scale (MMAS); however, there was a trend towards improved adherence based on MMAS. All physicians received timely intervention.This pilot study demonstrated that the protocol was feasible. It provided important insights about the need for intervention and the difficulties in treating patients with a variety of psychosocial problems that undercut their effective care.

SUBMITTER: Mangla A 

PROVIDER: S-EPMC4256535 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Congestive heart failure adherence redesign trial: a pilot study.

Mangla Ashvarya A   Doukky Rami R   Powell Lynda H LH   Avery Elizabeth E   Richardson DeJuran D   Calvin James E JE  

BMJ open 20141204 12


<h4>Objective</h4>Heart failure (HF) continues to be a leading cause of hospital admissions, particularly in underserved patients. We hypothesised that providing individualised self-management support to patients and feedback on use of evidence-based HF therapies (EBT) to physicians could lead to improvements in care and decrease hospitalisations. To assess the feasibility of conducting a larger trial testing the efficacy of this dual-level intervention, we conducted the Congestive Heart failure  ...[more]

Similar Datasets

| S-EPMC5729928 | biostudies-literature
| S-EPMC7426839 | biostudies-literature
2003-07-16 | GSE472 | GEO
2003-09-08 | GSE632 | GEO
2010-06-05 | E-GEOD-632 | biostudies-arrayexpress
| S-EPMC5064644 | biostudies-literature
| S-EPMC5542729 | biostudies-literature
| S-EPMC4280683 | biostudies-literature
| S-EPMC5215621 | biostudies-literature
| S-EPMC5380538 | biostudies-literature